BMC Cancer by King, Melony G et al.
King et al. BMC Cancer 2013, 13:94
http://www.biomedcentral.com/1471-2407/13/94RESEARCH ARTICLE Open AccessSugary food and beverage consumption and
epithelial ovarian cancer risk: a population-based
case–control study
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Background: Ovarian cancer is the deadliest gynecologic cancer in the US. The consumption of refined sugars has
increased dramatically over the past few decades, accounting for almost 15% of total energy intake. Yet, there is
limited evidence on how sugar consumption affects ovarian cancer risk.
Methods: We evaluated ovarian cancer risk in relation to sugary foods and beverages, and total and added sugar
intakes in a population-based case–control study. Cases were women with newly diagnosed epithelial ovarian
cancer, older than 21 years, able to speak English or Spanish, and residents of six counties in New Jersey. Controls
met same criteria as cases, but were ineligible if they had both ovaries removed. A total of 205 cases and 390
controls completed a phone interview, food frequency questionnaire, and self-recorded waist and hip
measurements. Based on dietary data, we computed the number of servings of dessert foods, non-dessert foods,
sugary drinks and total sugary foods and drinks for each participant. Total and added sugar intakes (grams/day)
were also calculated. Multiple logistic regression models were used to estimate odds ratios and 95% confidence
intervals for food and drink groups and total and added sugar intakes, while adjusting for major risk factors.
Results: We did not find evidence of an association between consumption of sugary foods and beverages and risk,
although there was a suggestion of increased risk associated with sugary drink intake (servings per 1,000 kcal;
OR=1.63, 95% CI: 0.94-2.83).
Conclusions: Overall, we found little indication that sugar intake played a major role on ovarian cancer
development.
Keywords: Ovarian cancer, Diet, Sugar, Sugary foods, Sugary drinks, Added sugars, Caloric sweeteners, Case–control,
Nutrition, Risk factorsBackground
Ovarian cancer is the ninth most common cancer
among women and ranks fifth in overall cancer deaths
in women in the United States [1]. Ovarian carcinogen-
esis is multifactorial and genetic, environmental, and
hormonal factors have been implicated [2]. Although the
relationship between diet and ovarian cancer has been
extensively evaluated, results are generally inconclusive* Correspondence: elisa.bandera@umdnj.edu
1The Cancer Institute of New Jersey, Robert Wood Johnson Medical School,
195 Little Albany St, New Brunswick NJ 08903, USA
2School of Public Health, University of Medicine and Dentistry of New Jersey,
Piscataway, NJ, USA
Full list of author information is available at the end of the article
© 2013 King et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the or[3,4]. Few studies [5-11] have examined the relationship
between sugary foods and beverages and risk of ovarian
cancer with inconclusive results. Furthermore, only one
study investigated the effects of added sugars on ovarian
cancer risk, finding an inverse association [12].
The World Cancer Research Fund/American Institute
for Cancer Research (WCRF/AICR) Second Expert Re-
port recommendations for cancer prevention include
limiting consumption of refined sugars [13]. Neverthe-
less, the consumption of caloric sweeteners has in-
creased rapidly in the United States over the past three
decades [14]. Even with a recent drop in added sugar
consumption by Americans older than 2 years, it stilld. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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exceeds the 2010 Dietary Guidelines for Americans that
recommend limiting calories from solid fats and added
sugars to 5 to 15% of total energy intake [15,16]. To our
knowledge this is the first study to evaluate ovarian can-
cer risk in relation to the consumption of sugary foods
and beverages, total and added sugar intakes, as well as
potential effect modification by insulin-related factors. It
also evaluates the relevance of the WCRF/AICR’s
recommendation to reduce sugar consumption in rela-
tion to ovarian cancer prevention. Understanding how
the consumption of sugar affects ovarian cancer risk
may further elucidate the role of diet in ovarian cancer
etiology, as well as provide some strategies for preven-
tion of this deadly disease.
Methods
Study population
The New Jersey Ovarian Cancer Study is a population-
based case–control study and has been described else-
where [17-19]. In brief, eligible women were older than
21 years, able to speak English and/or Spanish, and
residents of six contiguous counties in New Jersey
(Essex, Union, Morris, Middlesex, Bergen, and Hudson).
Cases were newly diagnosed, histologically confirmed
cases of invasive epithelial ovarian cancer, identified by
rapid case ascertainment by the New Jersey State Cancer
Registry, a SEER Registry. Population controls from the
EDGE (Estrogens, Diet, Genetics, and Endometrial Can-
cer) Study served as controls for this study and are
described elsewhere [20,21]. Briefly, controls were identi-
fied via random digit dialing (RDD) if under 65 years of
age and Centers for Medicare and Medicaid Services
(CMS) and area sampling if age 65+ years and 55+ years,
respectively. Recruitment of cases and controls occurred
between July 2001 and May 2008. Women who had a
hysterectomy or those who had a bilateral oophorectomy
were not eligible as controls in the NJ Ovarian Cancer
Study. Informed consent was obtained from all par-
ticipants. This study has been approved by the Institu-
tional Review Boards of the New Jersey Department of
Health and Senior Services, Memorial Sloan-Kettering
Cancer Center and University of Medicine and Dentistry
of New Jersey (UMDNJ) Robert Wood Johnson Medical
School.
Data collection
Same study procedures and materials were used for
cases and controls. Informed consent was obtained be-
fore the phone interview. Cases and controls completed
a phone interview during which a questionnaire was
administered ascertaining demographic characteristics
and major risk factors for the disease such as hormone
use, family history of cancer, reproductive history,medical history, and lifestyle factors up to a year prior to
diagnosis (or date of interview for controls). A food fre-
quency questionnaire (FFQ), the Block 98.2 FFQ (110
food items), was self-administered and returned by mail,
along with waist and hip measurements (a tape measure
and instructions were provided), and a mouthwash sam-
ple for DNA extraction.
We initially identified 682 eligible cases, of whom
some were excluded as they were either deceased (n=61)
or physicians advised us not to contact them (n=9).
Additional cases were excluded if they could not be
reached or no longer met eligibility requirements, such
as a communication barrier or medical conditions that
precluded participation (n=119). In total, 233 of the
remaining 493 cases (47%) and 467 controls (40%)
completed the phone interview. Participants were
excluded from the analysis if their menopausal status
was unknown or if they were missing other major
covariates. Those who were postmenopausal but did not
know their age at menopause were included in the ana-
lysis. Of the remaining cases and controls, 205 cases
(88%) and 398 controls (85%) completed both the inter-
view and FFQ. Eight of these controls were excluded
from these analyses because both of their ovaries had
been removed. There were no significant differences in
major characteristics between those who did and did not
complete the food frequency questionnaire.
Processing of dietary data
Participants’ responses were converted to number of
servings per day based on their reported frequency and
portion sizes for sugary foods and beverages. Frequency
was measured as ‘never’, ‘a few times per year’, ‘once per
month’, ‘2-3 times per month’, ‘once per week’, ‘2 time per
week’, ‘3-4 times per week’, ‘5-6 times per week’, and
‘everyday’ for most food items. For a few foods, ‘never’
and ‘a few times per year’ were combined into one
choice: ‘never or a few times per year’ and the choice of
‘2+ times per day’ was added. Portion size for food items
was measured in teaspoons, tablespoons, ounces,
pounds, cups, pieces, patties, bowls or slices. Portion
size for beverages was measured as number of cups,
glasses, cans or bottles consumed.
Serving sizes were based on the guidelines listed in
Reference Amounts Customarily Consumed (RACC) Per
Eating Occasion: General Food Supply by the Food and
Drug Administration (FDA) [22]. This document pro-
vides the amount of food typically consumed per ea-
ting occasion, and is based on the 1977-1978 and
1987-1988 Nationwide Food Consumption Surveys.
When making assumptions about participants’ portion
sizes consumed, we used the FDA’s assigned RACC
values as a guideline. For example, we assumed that one
doughnut (RACC=55 grams) is equivalent to one
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eating one doughnut per occasion were assigned as
eating one serving for this food item.
Next, we computed the number of servings of dessert
foods with added sugars, non-dessert foods with added
sugars, sugary drinks and total sugary foods and drinks
for each participant. Total and added sugar intakes (g/
day) were calculated for each relevant food item by
multiplying the frequency of intake by the total/added
sugar content per 100 grams of food.
Total sugars are the sum of both natural and added
sugars in the diet [14]. Natural sugars, like fructose or
lactose, are found in whole fruit, vegetables, or milk
products, which also have nutrients and phytochemicals
beneficial to an individual’s health [23]. Added sugars
are all caloric sweeteners that have been added to foods
or drinks during processing, preparation, and also
consumed separately or at the table. Foods and beve-
rages with added sugars tend to be high in calories and
lacking essential nutrients [23]. Examples of added
sugars are sucrose (i.e. table sugar), high fructose corn
syrup, honey, molasses, and syrups [14,15,23]. Sugary
foods and drinks are foods that have been processed,
prepared, or consumed with added sugars [23]. Total
and added sugar content values were based on the
USDA Database for Added Sugars Content of Selected
Foods [24].
Calculation of percent of calories from sweets and
desserts (% kcal from sweets) included the following
FFQ items: regular and low-fat ice cream, ice milk or ice
cream bars, doughnuts or Danish pastry, regular or low-
fat cake, sweet rolls or coffee cake, regular and low-fat
cookies, pumpkin pie or sweet potato pie, other pie or
cobbler, chocolate candy or candy bars, candy (not choc-
olate), soft drinks or sweetened bottled drinks like
Snapple (not diet), sugar or honey added to coffee/tea,
breakfast bars, granola bars or power bars, sweetened
cereals, and jelly, jam or syrup. Information about the
respondent’s consumption of diet drinks or use of non-
caloric sweeteners (within foods or added at the table)
was not collected.Statistical analyses
Descriptive statistics were computed for total and added
sugars and food and drink groups. For all analyses, stat-
istical significance was considered a p-value less than
0.05. To describe our study population, the distribution
of major characteristics for cases and controls was
tabulated. Two sample t-tests were used to compare
cases and controls across continuous variables and chi-
square tests were used for categorical variables. Age-
adjusted logistic regression models were used to calcu-
late odds ratios (ORs) and 95% confidence intervals(CIs) to compare ovarian cancer risk across major risk
factors (except for age).
ANCOVA was used to calculate age-adjusted means to
compare mean intake between cases and controls for
each food and drink group: dessert foods, non-dessert
foods, sugary drinks, total sugary foods and drinks, as
well as total and added sugar intakes. Based on the dis-
tribution in controls, tertiles for the food and drink
groups and total and added sugars intake were created
and frequencies calculated across the tertiles. Age-
adjusted and multiple unconditional logistic regression
models were used to estimate ORs and 95% CIs for the
food and drink groups and total and added sugar
intakes.
Covariates considered in multiple logistic regression
models include age (continuous), years of education
(≤12, 13-16, >16), race/ethnicity (White, Black, Other,
Hispanic-any race), age at menarche (>13, 12-13, ≤11),
menopausal status (pre- or postmenopausal) and age at
menopause for postmenopausal women (<40, 41-54,
≥55, age at menopause unknown), parity (0-1, 2, ≥3),
oral contraceptive (OC) use (ever vs. never), hormone
replacement therapy (HRT) use (never, unopposed estro-
gen only, any combined HRT), BMI (weight in kg/height
in m2; continuous), smoking status (never, past, current)
and pack-years (continuous) for ever smokers, physical
activity measured in continuous metabolic equivalents
(METs), tubal ligation (yes vs. no), dietary intakes of
fiber, total fat and saturated fat, and diabetes (yes vs. no).
We adjusted for total energy intake using the multivari-
ate nutrient density method [25]. Specifically, we com-
puted density measures for servings of sugary foods and/
or drinks per 1,000 kcal of intake, as well as grams of
total or added sugars per 1,000 kcal of intake and
included daily caloric intake as a continuous variable in
the multivariable models. Tests for trend were con-
ducted by assigning to each tertile the median value of
servings of sugary foods and/or drinks per 1,000 kcal or
total or added sugar intakes (g/1,000 kcal) among
controls. In addition, tertiles for percent of calories from
sweets and desserts (i.e. dessert foods group) per day
were created based on the controls, and frequencies
calculated across these tertiles. Odds ratios and 95% CIs
were calculated to assess ovarian cancer risk across these
tertiles.
Overweight or obesity is a strong determinant of insu-
lin resistance and hyperinsulinemia [26-30]. Addition-
ally, central obesity [31,32], which is related to insulin
resistance [33], has been shown to significantly increase
risk of ovarian cancer. We hypothesized that insulin-
related risk factors might modify the relationship be-
tween sugar intake and cancer risk. Thus, we explored
effect modification by factors capable of affecting the
body’s response to insulin production such as BMI
Table 1 Selected characteristics of women participating in the NJ ovarian cancer study
Cases (n=205) Controls (n=390) Age-adjusted
n (%) n (%) OR (95% CI)
Education
High school or less 61 (29.8) 132 (33.9) 1.00 (Ref)
College 93 (45.4) 159 (40.8) 0.90 (0.59-1.38)
Graduate school 51 (24.9) 99 (25.4) 0.76 (0.47-1.24)
Race/ethnicity
White 179 (87.3) 343 (88.4) 1.00 (Ref)
Black 9 (4.4) 17 (4.4) 1.02 (0.42-2.44)
Other 8 (3.9) 17 (4.4) 0.82 (0.33-1.99)
Hispanic (any race) 9 (4.4) 11 (2.8) 1.13 (0.44-2.92)
Parity*
0 – 1 97 (47.3) 92 (23.6) 1.00 (Ref)
2 60 (29.3) 136 (34.9) 0.45 (0.29-0.69)
≥3 48 (23.4) 162 (41.5) 0.42 (0.26-0.66)
Oral contraceptive use
Never 85 (41.5) 192 (49.2) 1.00 (Ref)
Ever 120 (58.5) 198 (50.8) 0.88 (0.61-1.28)
Use of HRT
Never 159 (77.6) 284 (72.8) 1.00 (Ref)
Unopposed E only 22 (10.7) 34 (8.7) 1.56 (0.86-2.83)
Any combined HRT 24 (11.7) 72 (18.5) 0.63 (0.38-1.06)
Age at menarche
>13 41 (20.1) 98 (25.2) 0.81 (0.51-1.28)
12-13 117 (57.4) 200 (51.4) 1.00 (Ref)
≤11 46 (22.6) 91 (23.4) 0.75 (0.48-1.17)
Menopause status*
Premenopausal 71 (34.6) 49 (12.6)
Postmenopausal 134 (65.4) 341 (87.4)
Age at menopause
<40 5 (2.4) 14 (3.6) 0.77 (0.26-2.31)
41-54 86 (42.0) 239 (61.3) 1.00 (Ref)
≥55 12 (5.9) 36 (9.3) 0.99 (0.48-2.02)
Unknown 31 (15.1) 52 (13.3) 1.52 (0.91-2.56)
BMI
Normal (<25) 91 (44.4) 180 (46.5) 1.00 (Ref)
Overweight (25-29.9) 54 (26.3) 122 (31.5) 1.07 (0.69-1.65)
Obese (30-34.9) 36 (17.6) 59 (15.3) 1.39 (0.83-2.32)
Very obese (≥35) 24 (11.7) 26 (6.7) 1.54 (0.82-2.89)
Smoking status
Never 108 (52.7) 203 (52.1) 1.00 (Ref)
Past 78 (38.1) 149 (38.2) 1.12 (0.76-1.64)
Current 19 (9.3) 38 (9.7) 0.87 (0.46-1.62)
Tubal ligation
No 175 (85.4) 314 (80.5) 1.00 (Ref)
Yes 30 (14.6) 76 (19.5) 0.59 (0.36-0.94)
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Table 1 Selected characteristics of women participating in the NJ ovarian cancer study (Continued)
First degree relative with ovarian cancer
No 195 (95.1) 376 (96.4) 1.00 (Ref)
Yes 10 (4.9) 14 (3.6) 1.32 (0.55-3.17)
OR: Odds Ratio, CI: Confidence Interval.
* p<0.01 for frequencies.
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kg/m2), waist-to-hip ratio (WHR; ≤0.85 vs. >0.85), or
physical activity (< median vs. ≥median for controls).
Odds ratios and 95% CIs were calculated for ovarian
cancer risk across tertiles for total sugary foods and
drinks and total and added sugars, stratified by these
factors. Because the number of women with diabetes
was too small to conduct separate analyses on them, we
also repeated analyses excluding women diagnosed with
diabetes. The Wald test was used to calculate p-values.Table 2 Age-adjusted means for sources of dietary sugars am
Sources of dietary sugars
Case
Total sugary foods & drinks (servings/1000 kcal) 5.1
Dessert foods (servings/1000 kcal) 0.8
Doughnuts, Danish pastry 0.0
Cakes, sweet rolls, coffee cake 0.0
Cookies 0.3
Ice cream 0.0
Pumpkin pie, sweet potato pie 0.0
Other pies or cobbler 0.0
Chocolate candy, candy bars 0.0
Other candy, not chocolate 0.2
Non-dessert foods (servings/1000 kcal) 3.9
Entrees 0.7
Canned fruit, dried fruits 0.0
Pancakes, waffles, French toast, Pop Tarts 0.0




Biscuits or muffins 0.7
Jelly, jam, or syrup 0.1
Other condiments 1.6
Sugary drinks (servings/1000 kcal) 0.3
Drinks with added vitamin C 0.0
Drinks with some fruit juices 0.0
Regular soft drinks or bottled drinks 0.1
Total sugars (g/1000 kcal) 64.6
Added sugars (g/1000 kcal) 29.4
SE: Standard Error.Results
Selected demographic characteristics and risk factors are
presented in Table 1. In our study population, participants
were mainly white and most had at least a college educa-
tion. Compared to controls, cases were younger (64.6 vs.
57.0 years, respectively; p<0.01, data not shown), more likely
to be either nulliparous or uniparous and premenopausal at
the time of diagnosis. Having two or more children,
combined HRT use and having a tubal ligation were
associated with lower risk of developing ovarian cancer.ong women in the NJ ovarian cancer study
Mean (SE) p
s (n=205) Controls (n=390)
2 (0.10) 4.83 (0.07) 0.39
7 (0.07) 0.83 (0.05) 0.64
4 (0.01) 0.04 (0.00) 0.85
3 (0.00) 0.03 (0.00) 0.40
7 (0.04) 0.39 (0.03) 0.25
6 (0.01) 0.05 (0.00) 0.03
1 (0.00) 0.01 (0.00) 0.72
2 (0.00) 0.02 (0.00) 0.11
8 (0.01) 0.07 (0.01) 0.11
8 (0.04) 0.24 (0.03) 0.81
4 (0.08) 3.80 (0.06) 0.39
0 (0.03) 0.59 (0.02) <0.001
4 (0.01) 0.04 (0.00) <0.01
6 (0.01) 0.07 (0.01) 0.89
3 (0.01) 0.03 (0.01) 0.08
7 (0.01) 0.11 (0.01) <0.001
5 (0.02) 0.17 (0.01) 0.36
8 (0.01) 0.08 (0.01) 0.72
9 (0.04) 0.80 (0.03) <0.01
5 (0.01) 0.15 (0.02) <0.01
1 (0.06) 1.53 (0.05) <0.01
0 (0.03) 0.24 (0.02) 0.17
1 (0.00) 0.01 (0.00) 0.35
1 (0.00) 0.01 (0.00) 0.97
2 (0.02) 0.09 (0.01) 0.18
6 (1.72) 60.15 (1.22) <0.01
6 (1.12) 26.25 (0.80) 0.07
Table 3 Sources of dietary sugars and ovarian cancer risk in the NJ ovarian cancer study
Sources of dietary sugars Cases (n=205) Controls (n=390) OR1 95% CI OR2 95% CI
Total sugary foods & drinks (servings/1000 kcal)
Continuous (per serving) 1.15 (1.02-1.31) 1.05 (0.90-1.22)
<4.14 50 (24.4) 130 (33.3) 1.00 1.00
4.14-5.37 74 (36.1) 130 (33.3) 1.45 (0.91-2.29) 1.25 (0.73-2.16)
>5.37 81 (39.5) 130 (33.3) 1.74 (1.10-2.74) 1.25 (0.73-2.17)
p trend 0.02 0.46
Dessert foods (servings/1000 kcal)
Continuous (per serving) 1.05 (0.87-1.27) 0.94 (0.75-1.17)
<0.35 68 (33.2) 132 (33.9) 1.00 1.00
0.35-0.80 66 (32.2) 128 (32.8) 0.99 (0.64-1.54) 0.92 (0.55-1.56)
>0.80 71 (34.6) 130 (33.3) 1.24 (0.79-1.94) 1.04 (0.61-1.76)
p trend 0.29 0.81
Non-dessert foods (servings/1000 kcal)
Continuous (per serving) 1.10 (0.95-1.29) 1.02 (0.85-1.23)
<3.21 52 (25.4) 132 (33.9) 1.00 1.00
3.21-4.20 73 (35.6) 128 (32.8) 1.47 (0.93-2.31) 1.30 (0.76-2.22)
>4.20 80 (39.0) 130 (33.3) 1.58 (1.01-2.48) 1.31 (0.77-2.24)
p trend 0.05 0.35
Sugary drinks (servings/1000 kcal)
Continuous (per serving) 1.53 (0.96-2.44) 1.63 (0.94-2.83)
<0.03 62 (30.2) 130 (33.3) 1.00 1.00
0.03-0.21 64 (31.2) 129 (33.1) 0.91 (0.59-1.44) 0.83 (0.48-1.41)
>0.21 79 (38.5) 131 (33.6) 1.17 (0.76-1.82) 1.09 (0.65-1.84)
p trend 0.30 0.47
Total sugars (g/1000 kcal)
Continuous (per 5g) 1.04 (1.00-1.08) 1.03 (0.99-1.08)
<49.33 68 (33.2) 129 (33.1) 1.00 1.00
49.33-69.61 70 (34.2) 130 (33.3) 1.19 (0.77-1.84) 1.32 (0.78-2.25)
>69.61 67 (32.7) 131 (33.6) 1.31 (0.84-2.04) 1.13 (0.66-1.94)
p trend 0.24 0.69
Added sugars (g/1000 kcal)
Continuous (per 5g) 1.07 (1.01-1.13) 1.04 (0.97-1.11)
<18.63 61 (31.2) 129 (33.1) 1.00 1.00
18.63-29.59 65 (33.2) 131 (33.6) 1.01 (0.64-1.59) 1.03 (0.59-1.77)
>29.59 79 (35.6) 130 (33.3) 1.35 (0.87-2.09) 1.05 (0.61-1.79)
p trend 0.16 0.87
% Kcal from sweets
<8.10 58 (28.3) 127 (32.6) 1.00 1.00
8.10-15.10 63 (30.7) 127 (32.6) 1.11 (0.70-1.76) 0.84 (0.49-1.46)
>15.10 84 (41.0) 136 (34.9) 1.40 (0.89-2.19) 1.10 (0.63-1.92)
p trend 0.13 0.57
OR: Odds Ratio, CI: Confidence Interval.
OR1: adjusted for age (continuous), daily caloric intake (continuous).
OR2: additionally adjusted for education (high school or less, college, graduate school), race (White, Black, Other, Hispanic), age at menarche (continuous),
menopausal status (premenopausal, postmenopausal) and age at menopause for postmenopausal women (<40, 42-54, ≥ 55, unknown), parity (0-1, 2, 3-4), oral
contraceptive use (ever, never), HRT use (never, unopposed estrogen only, any combined HRT), tubal ligation (no, yes), BMI (continuous), smoking status (never,
past, current) and pack-years for ever smokers (continuous), and physical activity (METs for reported average hours per week of moderate or strenuous
recreational activities).
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tion of sugary foods and drinks, as well as, total and
added sugars. Cases were more likely than controls to
consume dessert foods, non-dessert foods and sugary
drinks, although these differences were not significant.
However, cases had significantly greater mean total sugar
intake (64.7 vs. 60.2 grams/1,000 kcal, respectively), as
well as, higher added sugar intake (29.5 vs. 26.3 g/1,000
kcal, respectively) compared to controls, although the
latter did not reach statistical significance.
Multivariable analyses revealed an increased ovarian
cancer risk associated with higher consumption of total
sugary foods and drinks and sugary non-dessert foods
after adjusting for age and energy intake (Table 3). How-
ever, these associations did not remain significant after
further adjustment for additional risk factors. There was
a suggestion of a 63% increase in risk associated with
each additional serving of sugary drinks per 1,000 kcal
after adjusting for all risk factors, but the confidence
interval included the null value (OR=1.63, 95% CI: 0.94-
2.83). Further adjustment for diabetes, fiber, total fat, or
saturated fat intakes did not significantly change results
(data not shown). We also evaluated the impact of total
carbohydrate, glycemic index and glycemic load. While




































































Abbreviations: FFQ- food frequency questionnaire, DHQ- diet history questionnaire,
estrogen replacement therapy, OC- oral contraceptives, WHR- waist-to-hip ratio, “+Adjusted ORs (95% CI) for high vs. low quartiles were
1.18 (0.68-2.03) for total carbohydrate, 1.23 (0.71-2.14)
for glycemic index, and 1.59 (0.76-3.30) for glycemic
load (data not shown).
Stratified analyses by BMI, WHR, physical activity, oral
contraceptive use and menopausal status were based on
small numbers and did not provide clear evidence of ef-
fect modification (data not shown). We repeated ana-
lyses excluding HRT users and those with diabetes and
results were similar (data not shown).
Discussion
Our study provided little support for a relationship be-
tween ovarian cancer risk and intake of sugary foods and
beverages or total and added sugars. There was a sugges-
tion of a moderately increased cancer risk associated
with each additional serving of sugary drinks per 1,000
kcal, however, the confidence interval included the null
value.
Relatively few studies have previously evaluated the
role of intake of sugary food and beverages and total
added sugars on ovarian cancer risk (Tables 4 and 5). To
our knowledge, sugary beverage intake and ovarian can-
cer risk has only been evaluated in a few population-
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Abbreviations: BMI- body mass index, DHQ- diet history questionnaire, ERT- unopposed estrogen replacement therapy, FFQ- food frequency questionnaire, HRT-
hormone replacement therapy, OC- oral contraceptives, WHR- waist-to-hip ratio, “+ association” - positive association, “- association”- negative association 1 “Meat
and fat” category included processed and red meat, poultry, liver, high-energy drinks (Cola drinks, other soft drinks, and cordials) and sweetened foods (cake, tart
or pie, pastry, pavlova (meringue dessert), cheesecake, sweet roll, bun, plain sweet biscuits, fancy biscuits (e.g. chocolate coated), chocolate, lollies (candies), jam,
peanut butter, and sugar) 2 Bidoli (2002) and Bosetti (2001) were from the same study.
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conducted in Massachusetts and New Hampshire [11]
reported an association, with women who consumed the
highest level of caffeinated cola beverages having
elevated risk of ovarian cancer.
Only a few studies have reported on the impact of
various sugary foods on ovarian cancer risk, with incon-
clusive results. Similar to our results, Pan et al. [9] using
data from the Canadian National Enhanced Cancer
Surveillance System (NECSS), a population-based case–
control study in pre- and postmenopausal women, did
not find an association with baked desserts after
adjusting for multiple factors including BMI, total cal-
oric intake, and recreational physical activity [9].
Salazar-Martinez et al. [10] also did not find an associ-
ation with soda, coffee and tea combined (OR=0.96; 95%
CI: 0.40-2.29) in their hospital-based case–control study
in Mexico. It is worth noting, while the authors did ad-
just for total energy intake, recent changes in weight,
physical activity (METs), and diabetes, they did not ad-
just for smoking status or pack-years, BMI or WHR.
Similarly, two hospital-based case–control studies [5,10]
that have evaluated sugary food intake and risk of ovar-
ian cancer reported non-statistically significant increases
in risk associated with dessert consumption. In contrast,
Kushi et al. [7] found a strong adverse association be-
tween sweets and ovarian cancer risk in the Iowa
Women’s Health Study, a prospective study of almost
30,000 postmenopausal women among whom 139 cases
were identified during the follow-up period (ORs from
lowest to highest category: 1.00, 2.32, 2.49, and 1.61;
ptrend=0.17].
Overall, studies have produced inconsistent findings
on the relationship between dietary sugars (i.e. total
sugars, added sugar sucrose or fructose) and ovarian
cancer risk. Only two prospective studies [12,34] have
evaluated the relationship between sugar intake and
ovarian cancer with conflicting results. Interestingly,
using data from the NIH-AARP Diet and Health Study,
Tasevska et al. [12] found the risk of developing ovarian
cancer to be significantly inversely associated with totalsugars, total fructose, and sucrose [Hazard Ratio (HR)
(95% CI) for Quartile 5 vs. Quartile 1, respectively: 0.70
(0.51-0.97); 0.68(0.49-0.95); and 0.65(0.47-0.89)]. Unlike
our study, 97% of their 457 ovarian cancer cases were
postmenopausal and the authors state that their results
could be confounded by unknown factors. On the other
hand, Silvera et al. [34] did not detect a relationship be-
tween total sugar intake and ovarian cancer risk among
premenopausal women in a prospective cohort in
Canada. However, they did report increased risk with
total sugar intake (g/day) among postmenopausal
women (HRs from lowest to highest category: 1.00, 1.67,
2.35, and 1.79; ptrend=0.08). They also found no hete-
rogeneity of effects among pre- or postmenopausal
women by smoking status, parity, age at menarche, HRT
use, or alcohol intake [34]. Finally, among the studies
[5,10,12,17,34-41] that have evaluated sugar intake, only
one study [12] independently evaluated the effects of
added sugar on risk of developing ovarian cancer.
Tasevska et al. [12] detected significant protection
against ovarian cancer among women in the highest
quintile of added sugars intake, after adjusting for mul-
tiple factors [HR=0.72, 95% CI: (0.51-1.00); ptrend=0.02].
We also considered a potential effect modification by
physical activity, central adiposity, and general obesity,
and did not observe any significant heterogeneity of
effects estimates. Abdominal obesity [31] and high WHR
[32], both markers of insulin resistance [33], have been
shown to significantly increase ovarian cancer risk. Fur-
thermore, insulin encourages ovarian production of
androgens (direct precursors of estrogen synthesis)
[42-45] and controls metabolism and transport of
androgens in peripheral tissue [45]. This results in lower
levels of insulin-like growth factor-binding protein and
consequently increases insulin-like growth factor-1, pro-
moting ovarian carcinogenesis [32,34]. Insulin-related
factors, like WHR, might also modify the relationship
between sugar intake and cancer risk. Nagle and col-
leagues [35] found sugar intake to have a beneficial ef-
fect on ovarian cancer risk among normal weight
women and an adverse effect among overweight and
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women, insulin resistance would exaggerate the harmful
metabolic responses with carbohydrate consumption.
Thus, a high-sugar diet could possibly have a more dele-
terious effect on ovarian cancer risk among women who
are obese [35]. However, we did not find consistent evi-
dence that sugar consumption and ovarian cancer risk
was negatively impacted by central adiposity or excess
weight. The study of Nagle and colleagues [35] and our
study are the only studies to evaluate possible effect
modification by BMI and therefore additional studies are
needed. However, our study had limited statistical power
for these stratified analyses and results should only be
viewed as preliminary.
Recent studies have reported significant differences
across histologic subtypes in the associations of epithe-
lial ovarian cancer with reproductive and non-
reproductive risk factors, perhaps due to variations in
etiology, morphology, and genetic expression of ovarian
tumors [46,47]. Using data from the Nurses’ Health
Study and Nurses’ Health Study II, Gates et al. observed
that determinants such as age, duration of estrogen use,
BMI, duration of breastfeeding, age at menopause, and
smoking significantly differed by histologic subtype [46].
It is possible that our inability to detect a relationship
between sugar intake, ovarian cancer, and insulin
modifiers may be a result of variations in risk across
subtypes, which we were not able to evaluate due to
limited statistical power. To our knowledge, no other
studies have reported on sugar intake and ovarian cancer
risk by histological subtypes.
Some limitations of our study must be noted. First,
portion sizes were based on national food surveys
performed over twenty years ago. Using nationally rep-
resentative data collected between 1977 and 1996,
Nielsen and Popkin [48] observed notable increases in
US portion sizes for several food items including
desserts, soft drinks, and fruit drinks. Thus, it is pos-
sible that we underestimated sugar intake in both cases
and controls, resulting in non-differential exposure
misclassification and underestimation of the magni-
tude of the association. This is unlikely to have had a
major impact in estimates, however, as most of the
variance in intake is due to frequency and not portion
size [25]. Additionally, recall and selection biases are a
particular concern in case–control studies. Unlike our
study, two prospective cohort studies reported adverse
associations between sugar intake and ovarian cancer
risk among postmenopausal women [7,34]. It is con-
ceivable that in our study, cases tended to under-
report their sugar intake. We also assessed whether se-
lection bias might have occurred by comparing
characteristics of our ovarian cancer cases with all
women diagnosed with epithelial ovarian cancer in thesame NJ counties [49]. Our study participants were
younger than the general population of cases (median
age at diagnosis: 56 years vs. 61 years, respectively). On
the other hand, our cases were similar with respect to
race and ethnic distribution, as well as, histology, stage,
and grade of cancer. Similar to many other
epidemiologic studies [50], our study suffered from low
response rates (47% and 40% for cases and controls, re-
spectively). One concern is that participation may be
related to subjects’ lifestyle habits, particularly for
controls. For example, those who chose to participate
in our study may make healthier choices and be more
enthusiastic about participating in a health study than
those who refused. However, this issue is not unique to
our study, but a reality in medical research. Unfortu-
nately, we were unable to compare controls with
women who did not participate as we did not collect
information on those who could not be reached or
declined to participate in our study. However, we were
reassured that major selection bias may not have
affected our study as the distribution of major risk
factors is comparable to those reported in the
literature.
Conclusions
To our knowledge this is the first study to evaluate
ovarian cancer risk in relation to total and individual
consumption of sugary foods and beverages, total and
added sugar intake, as well as a potential effect modifi-
cation by several insulin-related risk factors. Although
in our study there was a suggestion of a moderately
increased cancer risk associated with sugary beverage
consumption, overall, we did not detect significant
relationships with any of the sugar variables evaluated.
The overall evidence for sugary foods and drinks and
added sugars remains inconclusive. These apparent
gaps in the literature emphasize the need for future re-
search, preferably large prospective studies, to evaluate
the role of added sugars in the etiology of ovarian can-
cer, while taking into consideration various factors
capable of influencing the body’s insulin response such
as anthropometric measures and physical activity.
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